Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Regulation of lymphatic endothelial cell specification

Award Number: F32HL162234
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 07/01/2022
PERIOD OF PERFORMANCE END DATE: 10/26/2022

Group Awards By:

View Award Description

Regulation of lymphatic endothelial cell specification - Project Summary The lymphatic circulation is a unique network of vessels lined by specialized lymphatic endothelial cells (LECs), which help regulate tissue fluid homeostasis, immune cell transport, and lipid absorption. Disruption in lymphatic vascular development leads to primary congenital lymphedema affecting 1 in 33,000 live born infants. There are no effective cures for lymphedema, and current therapies only help mitigate symptoms of the disease. It’s imperative to acquire a better understanding of the mechanisms that regulate lymphatic development in order to identify novel therapeutic targets for the treatment of lymphedema, fat malabsorption and immune surveillance. The lymphatic circulation develops in the embryo, shortly after the formation of the blood vasculature, in a series of steps including specification, migration and maturation to form the adult lymphatic circulation. In early embryonic development, a subset of venous endothelial cells in the cardinal vein are specified to become LECs. Newly specified LECs migrate out of the cardinal vein forming the primitive lymphatic capillary plexus, which is remodeled into the mature lymphatic circulation later in development. Although the progression of lymphatic vascular development has been well described, there is still a lot unknown about the mechanisms regulating LEC specification. Endothelial progenitor cells respond to a myriad of signaling cues to specify into either blood, hemogenic or lymphatic endothelial fates. Recently, cell cycle state has been identified as an important regulatory factor enabling the specification of different endothelial subtypes. Previous work from our lab has identified cell cycle arrest in early G1 to enable venous and hemogenic endothelial specification, whereas late G1 arrest promotes arterial fate determination. Thus, different endothelial cell cycle states dynamically regulate endothelial cell phenotype by creating “windows of opportunity” for different fate commitments. Although there is a growing appreciation for the role of cell cycle control in blood and hemogenic endothelial cell specification, its contribution to LEC fate commitment during early embryogenesis remains unexplored. Our preliminary data show that disruption of cell cycle control impairs normal LEC specification and lymphatic vascular maturation, supporting a key role for cell cycle regulation during lymphatic development. This proposal will test the hypothesis that G1 cell cycle arrest enables LEC specification from venous endothelial cells during early embryogenesis. Using Fucci cell cycle reporter mice in which distinct cell cycle states can be discerned, and novel LEC-specific knockout mouse models, we will investigate the underlying mechanisms regulating endothelial cell cycle control and LEC specification during development. Results from these studies will help to understand the key mechanisms at play during lymphatic vascular development and may elucidate novel therapeutic targets for the treatment of primary lymphedemas.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = -$47,957 )
2023	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 EMMET ST N	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	002	1	9/27/2023	NEW	$0
2023	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 EMMET ST N	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	001	1	8/30/2023	NEW	$0
2023	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	000	1	12/12/2022	NEW	-$47,957
														Subtotal = -$47,957

Issue Date FY: 2022 ( Subtotal = $67,582 )
2022	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	000	1	2/14/2022	NEW	$66,390
2022	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	001	1	6/10/2022	NEW	$1,192
2022	2022	RECTOR & VISITORS OF THE UNIVERSITY OF VIRGINIA	1001 N EMMET ST	CHARLOTTESVILLE	VA	22903	CHARLOTTESVILLE CITY	USA	Cardiovascular Diseases Research	002	1	6/10/2022	NEW	$0
														Subtotal = $67,582

Grand Total All Awards = $19,625

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Regulation of lymphatic endothelial cell specification

Award Number: F32HL162234

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 07/01/2022

PERIOD OF PERFORMANCE END DATE: 10/26/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer